tirzepatide news october 2025 FDA Says Compounded Must Exit the Market World Health Organization issues first-ever

In an interview with Korea Biomedical Review last month, he noted that older adults on the medicines lose more muscle, and Korea has no consensus on the age to start or stop

In line with current recommendations, the USPSTF advises routine depression screening in adults (B recommendation), while evidence remains insufficient to recommend for or against routine suicide-risk screening (I statement) [102]

cyanocobalamin) To get the most from your B12 supplement, timing is key

Separating Hype From Science GLP-1 medications are: Evidence-based Clinically powerful Life-changing for many patients They are not : Vanity drugs Risk-free One-size-fits-all Sciencenot social mediashould guide treatment decisions

46.8% Weight loss therapy contribution to drug-spend increase

Unlike many peptides that are unstable in physiological conditions, BPC-157 has demonstrated remarkable stability in both acidic (gastric) and neutral (plasma) environments in published research a property that has made it one of the most studied peptides for tissue repair across more than 100 independent pre-clinical investigations